Overview

The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers

Status:
Completed
Trial end date:
2016-09-05
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the systemic exposures of WH-1 ointment which includes Salvigenin and Asiaticoside A in subjects with chronic diabetic foot ulcers following topical application of WH-1.
Phase:
Phase 1
Details
Lead Sponsor:
Oneness Biotech Co., Ltd.